Shai Lankry, MBA

Chief Communications Officer

Mr. Lankry supports several companies as a strategic fractional Chief Financial Officer through his firm, LS Consulting Services. From 2018 to 2023, Mr. Lankry served as the Chief Financial Officer of Gamida Cell Ltd. (formerly, Nasdaq: GMDA). Prior to that, from 2016 to 2018, Mr. Lankry served as Finance Director at West Pharmaceutical Services, Inc. (NYSE: WST), leading the financial aspects of research and development and operations for its Israeli subsidiary. From 2013 to 2017, Mr. Lankry served as the Chief Financial Officer and Israeli site manager of MacroCure Ltd. (formerly, Nasdaq: MCUR), where he played an integral role in its 2014 initial public offering in the United States and its 2017 acquisition by Leap Therapeutics Inc. (Nasdaq: LPTX). Mr. Lankry is a licensed certified public accountant and holds an M.B.A. degree in Finance from Tel-Aviv University.